Receptors, Pituitary Hormone-Regulating Hormone
"Receptors, Pituitary Hormone-Regulating Hormone" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Cell surface receptors that bind the hypothalamic hormones regulating pituitary cell differentiation, proliferation, and hormone synthesis and release, including the pituitary-releasing and release-inhibiting hormones. The pituitary hormone-regulating hormones are also released by cells other than hypothalamic neurons, and their receptors also occur on non-pituitary cells, especially brain neurons, where their role is less well understood. Receptors for dopamine, which is a prolactin release-inhibiting hormone as well as a common neurotransmitter, are not included here.
Below are MeSH descriptors whose meaning is more general than "Receptors, Pituitary Hormone-Regulating Hormone".
Below are MeSH descriptors whose meaning is more specific than "Receptors, Pituitary Hormone-Regulating Hormone".
This graph shows the total number of publications written about "Receptors, Pituitary Hormone-Regulating Hormone" by people in Harvard Catalyst Profiles by year, and whether "Receptors, Pituitary Hormone-Regulating Hormone" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1993 | 1 | 0 | 1 |
| 1994 | 1 | 0 | 1 |
| 1997 | 1 | 0 | 1 |
| 1999 | 1 | 0 | 1 |
| 2001 | 1 | 0 | 1 |
| 2002 | 3 | 0 | 3 |
| 2003 | 1 | 0 | 1 |
| 2007 | 0 | 1 | 1 |
| 2017 | 1 | 0 | 1 |
Below are the most recent publications written about "Receptors, Pituitary Hormone-Regulating Hormone" by people in Profiles.
-
Growth hormone deficiency with advanced bone age: phenotypic interaction between GHRH receptor and CYP21A2 mutations diagnosed by sanger and whole exome sequencing. Arch Endocrinol Metab. 2017 Dec; 61(6):633-636.
-
Growth hormone-releasing hormone antagonists abolish the transactivation of human epidermal growth factor receptors in advanced prostate cancer models. Invest New Drugs. 2014 Oct; 32(5):871-82.
-
Inhibitory effects of antagonists of growth hormone-releasing hormone on growth and invasiveness of PC3 human prostate cancer. Int J Cancer. 2013 Feb 15; 132(4):755-65.
-
Modulation of pancreatic islets-stress axis by hypothalamic releasing hormones and 11beta-hydroxysteroid dehydrogenase. Proc Natl Acad Sci U S A. 2011 Aug 16; 108(33):13722-7.
-
Common genetic variation in eight genes of the GH/IGF1 axis does not contribute to adult height variation. Hum Genet. 2007 Sep; 122(2):129-39.
-
Cdk4 is indispensable for postnatal proliferation of the anterior pituitary. J Biol Chem. 2004 Dec 03; 279(49):51100-6.
-
A new missense mutation in the growth hormone-releasing hormone receptor gene in familial isolated GH deficiency. Eur J Endocrinol. 2003 Jan; 148(1):25-30.
-
Pulsatile growth hormone secretion persists in genetic growth hormone-releasing hormone resistance. Am J Physiol Endocrinol Metab. 2002 Apr; 282(4):E943-51.
-
Decreased expression of the GHRH receptor gene due to a mutation in a Pit-1 binding site. Mol Endocrinol. 2002 Mar; 16(3):450-8.
-
Expression of a splice variant of the receptor for GHRH in 3T3 fibroblasts activates cell proliferation responses to GHRH analogs. Proc Natl Acad Sci U S A. 2002 Jan 08; 99(1):196-200.